Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder : original investigations

Objectives Previous studies indicated a relationship between aldosterone, the mineralocorticoid receptor (MR), and antidepressant treatment outcome. Physiological indicators of MR function (blood pressure and electrolytes) are easily accessible and may therefore serve as useful predictors. Thus, our...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Engelmann, Jan (VerfasserIn) , Murck, Harald (VerfasserIn) , Wagner, Stefanie (VerfasserIn) , Zillich, Lea (VerfasserIn) , Streit, Fabian (VerfasserIn) , Herzog, David P. (VerfasserIn) , Braus, Dieter F. (VerfasserIn) , Tadic, Andre (VerfasserIn) , Lieb, Klaus (VerfasserIn) , Müller, Marianne B. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 Jan 2022
In: The world journal of biological psychiatry
Year: 2022, Jahrgang: 23, Heft: 8, Pages: 631-642
ISSN:1814-1412
DOI:10.1080/15622975.2021.2020334
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/15622975.2021.2020334
Verlag, lizenzpflichtig, Volltext: https://www.tandfonline.com/doi/abs/10.1080/15622975.2021.2020334?journalCode=iwbp20
Volltext
Verfasserangaben:Jan Engelmann, Harald Murck, Stefanie Wagner, Lea Zillich, Fabian Streit, David P. Herzog, Dieter F. Braus, Andre Tadic, Klaus Lieb and Marianne B. Műller

MARC

LEADER 00000caa a22000002c 4500
001 185984863X
003 DE-627
005 20240307084119.0
007 cr uuu---uuuuu
008 230918s2022 xx |||||o 00| ||eng c
024 7 |a 10.1080/15622975.2021.2020334  |2 doi 
035 |a (DE-627)185984863X 
035 |a (DE-599)KXP185984863X 
035 |a (OCoLC)1425216734 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Engelmann, Jan  |e VerfasserIn  |0 (DE-588)1264812205  |0 (DE-627)1813399549  |4 aut 
245 1 0 |a Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction  |b a post-hoc analysis from the early medication change trial in major depressive disorder : original investigations  |c Jan Engelmann, Harald Murck, Stefanie Wagner, Lea Zillich, Fabian Streit, David P. Herzog, Dieter F. Braus, Andre Tadic, Klaus Lieb and Marianne B. Műller 
264 1 |c 25 Jan 2022 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.09.2023 
520 |a Objectives Previous studies indicated a relationship between aldosterone, the mineralocorticoid receptor (MR), and antidepressant treatment outcome. Physiological indicators of MR function (blood pressure and electrolytes) are easily accessible and may therefore serve as useful predictors. Thus, our aim was to investigate the predictive value of peripheral MR-related markers for antidepressant treatment outcomes.Methods 826 MDD patients who had participated in the randomised-controlled Early Medication Change (EMC) trial were analysed. Depression severity and MR-related markers were assessed weekly. In 562 patients, genetic variation of five MR-related genes was determined.Results Patients with blood pressure <120mmHg showed higher depression severity (p = 0.005) than patients with blood pressure ≥120mmHg. Patients with a melancholic subtype had significantly lower blood pressures (p = 0.004). Na+/K+ ratio was positively and K+-concentration was negatively correlated to depression severity and to relative changes in HAMD from baseline to day 14, and 56 respectively (p < 0.001). For none of the MR-related genes, genetic variation was associated with treatment outcomes.Conclusions We confirmed early observations of an altered peripheral MR sensitivity, reflected by lower blood pressure, low K+ or high Na+/K+ ratio in patients with more severe depression. These routinely collected biomarkers may potentially be useful for risk stratification in an early stage of treatment. Trial Registration: clinicaltrials.gov Identifier: NCT00974155; https://www.clinicaltrials.gov/ct2/results?term=NCT00974155 
650 4 |a aldosterone 
650 4 |a biomarker 
650 4 |a Major depressive disorder 
650 4 |a mineralocorticoid receptor 
650 4 |a treatment outcome 
700 1 |a Murck, Harald  |e VerfasserIn  |4 aut 
700 1 |a Wagner, Stefanie  |e VerfasserIn  |4 aut 
700 1 |a Zillich, Lea  |d 1994-  |e VerfasserIn  |0 (DE-588)1133523404  |0 (DE-627)889399670  |0 (DE-576)489474969  |4 aut 
700 1 |a Streit, Fabian  |d 1982-  |e VerfasserIn  |0 (DE-588)113749199X  |0 (DE-627)894689843  |0 (DE-576)491387970  |4 aut 
700 1 |a Herzog, David P.  |e VerfasserIn  |4 aut 
700 1 |a Braus, Dieter F.  |e VerfasserIn  |4 aut 
700 1 |a Tadic, Andre  |e VerfasserIn  |4 aut 
700 1 |a Lieb, Klaus  |d 1965-  |e VerfasserIn  |0 (DE-588)106065378  |0 (DE-627)597664331  |0 (DE-576)161986897  |4 aut 
700 1 |a Müller, Marianne B.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t The world journal of biological psychiatry  |d Abingdon : Taylor & Francis Group, 2000  |g 23(2022), 8, Seite 631-642  |h Online-Ressource  |w (DE-627)474385051  |w (DE-600)2170223-8  |w (DE-576)27773293X  |x 1814-1412  |7 nnas  |a Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction a post-hoc analysis from the early medication change trial in major depressive disorder : original investigations 
773 1 8 |g volume:23  |g year:2022  |g number:8  |g pages:631-642  |g extent:12  |a Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction a post-hoc analysis from the early medication change trial in major depressive disorder : original investigations 
856 4 0 |u https://doi.org/10.1080/15622975.2021.2020334  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.tandfonline.com/doi/abs/10.1080/15622975.2021.2020334?journalCode=iwbp20  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230918 
993 |a Article 
994 |a 2022 
998 |g 113749199X  |a Streit, Fabian  |m 113749199X:Streit, Fabian  |d 60000  |e 60000PS113749199X  |k 0/60000/  |p 5 
998 |g 1133523404  |a Zillich, Lea  |m 1133523404:Zillich, Lea  |d 60000  |e 60000PZ1133523404  |k 0/60000/  |p 4 
999 |a KXP-PPN185984863X  |e 4377470515 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction","title":"Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction","subtitle":"a post-hoc analysis from the early medication change trial in major depressive disorder : original investigations"}],"person":[{"family":"Engelmann","display":"Engelmann, Jan","given":"Jan","role":"aut"},{"given":"Harald","role":"aut","display":"Murck, Harald","family":"Murck"},{"family":"Wagner","display":"Wagner, Stefanie","role":"aut","given":"Stefanie"},{"family":"Zillich","display":"Zillich, Lea","given":"Lea","role":"aut"},{"given":"Fabian","role":"aut","display":"Streit, Fabian","family":"Streit"},{"family":"Herzog","display":"Herzog, David P.","given":"David P.","role":"aut"},{"family":"Braus","given":"Dieter F.","role":"aut","display":"Braus, Dieter F."},{"given":"Andre","role":"aut","display":"Tadic, Andre","family":"Tadic"},{"family":"Lieb","role":"aut","given":"Klaus","display":"Lieb, Klaus"},{"family":"Müller","display":"Müller, Marianne B.","given":"Marianne B.","role":"aut"}],"name":{"displayForm":["Jan Engelmann, Harald Murck, Stefanie Wagner, Lea Zillich, Fabian Streit, David P. Herzog, Dieter F. Braus, Andre Tadic, Klaus Lieb and Marianne B. Műller"]},"relHost":[{"pubHistory":["1.2000 -"],"language":["eng"],"part":{"year":"2022","text":"23(2022), 8, Seite 631-642","volume":"23","extent":"12","pages":"631-642","issue":"8"},"title":[{"title":"The world journal of biological psychiatry","title_sort":"world journal of biological psychiatry"}],"origin":[{"dateIssuedKey":"2000","publisher":"Taylor & Francis Group ; Informa Healthcare","dateIssuedDisp":"2000-","publisherPlace":"Abingdon ; London [u.a.]"}],"recId":"474385051","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 01.09.15"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction a post-hoc analysis from the early medication change trial in major depressive disorder : original investigationsThe world journal of biological psychiatry","id":{"zdb":["2170223-8"],"issn":["1814-1412"],"eki":["474385051"]}}],"note":["Gesehen am 18.09.2023"],"id":{"eki":["185984863X"],"doi":["10.1080/15622975.2021.2020334"]},"physDesc":[{"extent":"12 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"185984863X","origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"25 Jan 2022"}]} 
SRT |a ENGELMANNJROUTINELYA2520